News
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 13 cents in second-quarter 2025, narrower than the year-ago adjusted loss of 20 cents
Take-Two's Q1 Loss Narrows Year Over Year, Revenue Growth Continues
TakeTwo Interactive Software TTWO incurred a first-quarter fiscal 2026 GAAP net loss of 7 cents per share, narrower than a loss of $1.52 reported in the year-ago quarter. The Zacks Consensus
DASH Q2 Benefits From Strong Marketplace GOV: Time to Buy the Stock?
DoorDash’s DASH second-quarter 2025 Marketplace GOV increased 23% year over year to $24.2 billion. The figure beat the Zacks Consensus mark by 2.67%. Growth can be attributed to strong demand across
The Beachbody Company (BODI) Upgraded to Buy: Here's What You Should Know
The Beachbody Company, Inc. (BODI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in
Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on Lexicon Pharmaceuticals (LXRX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings
Vertical Aerospace (EVTL) Upgraded to Buy: Here's What You Should Know
Vertical Aerospace Ltd. (EVTL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates
Limbach (LMB) Upgraded to Buy: Here's Why
Limbach (LMB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices
All You Need to Know About Personalis (PSNL) Rating Upgrade to Buy
Investors might want to bet on Personalis (PSNL), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock
Tree.com (TREE) Upgraded to Strong Buy: Here's What You Should Know
Investors might want to bet on Tree.com (TREE), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --
All You Need to Know About Wex (WEX) Rating Upgrade to Strong Buy
Investors might want to bet on Wex (WEX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
Powell Industries (POWL) Upgraded to Buy: Here's What You Should Know
Powell Industries (POWL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one
All You Need to Know About Holley (HLLY) Rating Upgrade to Buy
Holley Inc. (HLLY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of
Are You Looking for a Top Momentum Pick? Why CaixaBank, S.A. Unsponsored ADR (CAIXY) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Corning (GLW) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
What Makes OppFi (OPFI) a New Buy Stock
Investors might want to bet on OppFi Inc. (OPFI), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock
What Makes Lumentum (LITE) a Strong Momentum Stock: Buy Now?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
For weight loss drug leaders, the last two weeks have been nothing short of disastrous for shares.
Industry pioneer Novo Nordisk A/S (NYSE: NVO) saw its stock drop nearly 22% on July 29 after
Can Chipotle's Equipment Upgrades Fix Peak-Hour Bottlenecks?
Chipotle Mexican Grill, Inc. CMG is actively investing in enhancing its sales performance across all its restaurants, targeted mainly during peak hours or peak period of the season, ensuring
Brighthouse Financial Q2 Earnings Miss Estimates on Lower Premiums
Brighthouse Financial, Inc. BHF reported second-quarter 2025 adjusted earnings of $3.43 per share, which missed the Zacks Consensus Estimate by 27%. The bottom line declined 38.4% year over year.
Akamai Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
Akamai Technologies, Inc. AKAM reported strong second-quarter 2025 results, with both the top and bottom lines surpassing the Zacks Consensus Estimate.The company reported a top-line expansion year
Can China Momentum Balance Starbucks' U.S. Comps Challenges?
Starbucks Corporation SBUX is leaning on the fastest-growing international market as it navigates softer results in the United States. With consumer behavior shifting and competitive pressures
CBL Stock Rises Following Q2 Earnings and Mall Acquisitions
Shares of CBL & Associates Properties, Inc. CBL have gained 0.6% since the company reported its earnings for the quarter ended June 30, 2025, compared to the S&P 500 Index’s 0.8% loss over the same
Should You Buy, Hold or Sell UUUU Stock Post Q2 Earnings?
Energy Fuels UUUU reported second-quarter 2025 results on Aug. 6, which fell short of expectations and also declined from the prior-year quarter. The company reported a loss of 10 cents, wider than
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity, Inc. DOCS delivered adjusted earnings per share (EPS) of 36 cents in the first quarter of fiscal 2026, which increased 28.6% year over year. The figure surpassed the Zacks Consensus
Microchip Q1 Earnings Beat Estimates, Sales Down Y/Y, Shares Drop
Microchip Technology MCHP reported first-quarter fiscal 2026 non-GAAP earnings of 27 cents per share, which beat the Zacks Consensus Estimate by 12.5% but fell 49.1% year over year.Net sales of


